logo

Jazz Pharmaceuticals Plc (JAZZ)



Trade JAZZ now with
  Date
  Headline
2/17/2020 2:33:42 AM PharmaMar And Jazz Pharma Announce FDA Acceptance And Priority Review Of NDA For Lurbinectedin
1/22/2020 8:11:10 AM Jazz Submits NDA For JZP-258 For Cataplexy And Excessive Daytime Sleepiness Associated With Narcolepsy
1/22/2020 2:40:10 AM PharmaMar, Jazz U.S. License Agreement For Lurbinectedin Effective With Expiration Of HSR Waiting Period
1/20/2020 11:25:20 AM Jazz Pharma Gets EU Marketing Approval For Sunosi For Excessive Daytime Sleepiness In Adults With Narcolepsy
12/30/2019 8:07:33 AM Jazz:First Patient Enrolled In Pivotal Phase 2/3 Study Evaluating JZP-458 For Treatment Of Acute Lymphoblastic Leukemia
12/19/2019 8:02:26 AM PharmaMar And Jazz Sign License Agreement For Lurbinectedin In U.S.; Jazz To Pay Upfront Payment Of $200 Mln
11/15/2019 6:46:32 AM Jazz Pharma Receives Positive CHMP Opinion For Solriamfetol
8/12/2019 4:06:20 PM Jazz Pharmaceuticals Announces Acquisition Of Cavion
7/10/2019 2:02:38 AM Jazz Acquires Pre-clinical Pan-RAF Inhibitor Program From Redx Pharma; Redx To Get Up To $203 Mln In Milestone Payments
6/17/2019 8:06:16 AM Jazz Pharma Receives Schedule IV Designation From DEA For Sunosi
5/7/2019 4:06:40 PM Jazz Pharma Q1 EPS $1.47 Vs. $0.75 Yea Rago
  
 
>